glp 1 agonist news GLP-1 receptor agonists show promise in treating substance use disorders glp-1 receptor agonist news Research

J Agric Food Chem (2014) 62:614758

When comparing the responders from the CRWP group ( n = 12) to the non-responders in the same group ( n = 7), there was a significant difference in age with the responders being significantly older (4.23 0.22 years) than non-responders (3.48 0.18 years

For acute conditions such as injuries or acute illness, the effects of peptide therapy may be felt within days to weeks

Heres a shortlist [3]: Yawning Stretching Decreased appetite Increased sexual arousal and libido Darkening facial hair Darkening moles Flushing Nausea Lethargy Dizziness Despite these side effects, a review of research on melanotan 2 has concluded that side effects observed in clinical trials are largely minor [3]